- Home
- SUIG vs ORGO Comparison
SUIG vs ORGO Comparison
Compare SUIG & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUIG | ORGO |
|---|---|---|
| Founded | 2006 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.3M | 127.6M |
| IPO Year | 2022 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SUIG | ORGO |
|---|---|---|
| Price | $0.99 | $0.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $2.70 | $2.00 |
| AVG Volume (30 Days) | 445.8K | ★ 1.1M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | ★ N/A | N/A |
| Revenue | $3,898,631.00 | ★ $564,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $120.04 | $37.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.10 | 17.04 |
| 52 Week Low | $0.79 | $0.73 |
| 52 Week High | $2.84 | $7.08 |
Technical Indicators
Market Signals| Indicator | SUIG | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 35.13 | 39.51 |
| Support Level | $0.86 | N/A |
| Resistance Level | $1.54 | $2.58 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 20.00 | 43.09 |
Price Performance
Historical ComparisonAbout SUIG Sui Group Holdings Limited
Sui Group Holdings Ltd operates a treasury management business. It has established a publicly traded SUI treasury, backed by an exclusive relationship with the Sui Foundation, an independent organization dedicated to the advancement and adoption of the Sui network. The company executes its business by acquiring SUI tokens through open-market purchases, institutional-grade deal flow typically reserved for cryptocurrency funds, and a negotiated purchase agreement with the Sui Foundation. It is focused on capitalizing on technology trends and ecosystem growth relating to SUI, while providing liquid and institutional-grade access to blockchains. The company has one reportable segment, which is a digital asset platform focused on maximizing SUI per share value and advancing the Sui ecosystem.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.